explore -WSS

explore

author：focus 2025-09-03 09:23:01 - browse：298

Are there still too many biotech companies? How do you know when you’re in a bubble? And is there a wrong way to pronounce “TIGIT”?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Josh Schimmer and Eric Schmidt, two longtime analysts teaming up at Cantor Fitzgerald, join us for a back-to-school conversation as biotech enters the busy back third of 2023. We also discuss the latest news in the life sciences, including some scientific evolution at Biogen, new leadership at Illumina, and the future of CRISPR medicine.

For more on what we cover, here’s the news from Biogen; here’s more on Illumina; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

hotspot

knowledge

WSS

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

What Mike Pence has said that could be used in a Donald Trump trial

It's been 20 years since Dolly the sheep. Where's my clone?

My superpower is killing ticks

How AI helped researchers track recovery from depression

entertainment

explore

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Senate HELP committee spars over health care workforce policies

In Memoriam: Notable people who died in 2023

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

New air purifier tech could be key to improving indoor air quality

Nearly two

Continuity nursing helped my family in our darkest PICU moments

Intarcia’s device

Psychedelics group wrestles with new pharma identity

Nearly two

focus

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

How Vertex's cystic fibrosis drug is changing patients' lives

OTC birth control: A brief history of over the counter pill design

Dramatically reducing cancer deaths requires the PASTEUR Act

Nearly two

2 US Navy sailors arrested for allegedly spying for China

hotspot

knowledge

explore

hotspot